Skip to content

Evaluation of Topical Bevacizumab in Trabeculectomy

Evaluation of topical Bevacizumab in sutureless Trabeculectomy in glaucoma patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017041433424N1
Enrollment
20
Registered
2017-05-27
Start date
2017-05-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma. Glaucoma (primary)(residual stage):chronic simple

Interventions

Intervention 1: Control group : Sutureless Trabeculectomy ( 10 patients). Intervention 2: Intervention group : Sutureless trabecuectomy with 1.25 mg topical bevacizumab , one time ( 10 patinets).
Treatment - Surgery
Control group : Sutureless Trabeculectomy ( 10 patients)
Intervention group : Sutureless trabecuectomy with 1.25 mg topical bevacizumab , one time ( 10 patinets)

Sponsors

Vice chancellor for research, Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: intraocular pressure (IOP)>21 mmHg despite maximum tolerated medication and poor compliance leading to POAG. Exclusion criteria : history of ocular surgery, congenital glaucoma, ocular inflammation, angle closure glaucoma, secondrty open angle glaucoma and soft tissue disease (Marfan syndrome, collagen vascular diseases etc.)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intra ocular pressure. Timepoint: before study and 1month and 6 months post operation. Method of measurement: goldman tenometer.

Secondary

MeasureTime frame
Visual acuity. Timepoint: before study and 1month and 6 months post operation. Method of measurement: snelen chart.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactOmid Bagherzadeh

Zahedan Alzahra Eye Hospital

o.bagherzadeh@gmail.com+98 543233551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026